Back to Gastroenterology
GastroenterologyvModified_1984Evidence-Based

Glasgow-Imrie Criteria for Severity of Acute Pancreatitis

Clinical scoring system to assess the severity of acute pancreatitis using 8 laboratory and clinical parameters. Helps predict mortality risk and guide management decisions including ICU admission and treatment intensity. Uses the PANCREAS mnemonic for easy recall.

Clinical Input Parameters

mmHg
Range: 30 — 150 mmHg
years
Range: 18 — 120 years
×10⁹/L
Range: 1 — 50 ×10⁹/L
mg/dL
Range: 4 — 15 mg/dL
mg/dL
Range: 5 — 200 mg/dL
IU/L
Range: 100 — 5000 IU/L
g/dL
Range: 1 — 6 g/dL
mg/dL
Range: 50 — 800 mg/dL
Clinical Assessment
Awaiting Parameters
glasgow imrie score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Glasgow-Imrie Criteria for Severity of Acute Pancreatitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Glasgow-Imrie Score = Sum of positive criteria: PaO2 <59.3 mmHg (1 point) + Age >55 years (1 point) + WBC >15×10⁹/L (1 point) + Calcium <8 mg/dL (1 point) + Urea >44.8 mg/dL (1 point) + LDH >600 IU/L (1 point) + Albumin <3.2 g/dL (1 point) + Glucose >180 mg/dL (1 point)

Clinical Pearls & Practice Notes

  • Originally developed as modification of Ranson's criteria for acute pancreatitis
  • Uses PANCREAS mnemonic: PaO2, Age, Neutrophils, Calcium, Renal function, Enzymes, Albumin, Sugar
  • Should be assessed within 48 hours of admission for accurate prognostication
  • Score ≥3 indicates significant likelihood of severe pancreatitis
  • More than 3 positive criteria may require ICU transfer
  • Developed in 1980s, predating modern pancreatitis management guidelines
  • Comparable predictive accuracy to Ranson's criteria
  • Does not include imaging findings (unlike modern severity scores)
  • Should be used in conjunction with clinical assessment and imaging
  • APACHE II score may be more useful for daily monitoring
  • Consider modern scoring systems like BISAP or SIRS for additional assessment
  • Not recommended as sole determinant for surgical intervention
  • Mortality risk correlates with score but also depends on age and comorbidities
  • Early identification of severe cases allows for appropriate resource allocation

Evidence & Literature Citations

  1. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65(5):337-341.
  2. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984;25(12):1340-1346. doi: 10.1136/gut.25.12.1340.
  3. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139(1):69-81.
  4. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111. doi: 10.1136/gutjnl-2012-302779.

Score Interpretation Ranges

Mild Pancreatitis0 – 2 pts

Low risk for severe pancreatitis

Moderate Pancreatitis3 – 4 pts

Moderate risk for severe pancreatitis

Severe Pancreatitis5 – 8 pts

High risk for severe pancreatitis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.